Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Emergency Drugs |Emergency Drug Antidotes |Emergency Cardiac Drugs |Emergency Endocrine Drugs |Emergency Gastrointestinal Drugs |Emergency Haematology Drugs |Emergency Neuropsychiatric drugs |Emergency Pain drugs |Emergency Respiratory drugs |Emergency Obstetric and Gynaecology Drugs |Emergency Paediatric Drugs
DRUG | MOA | DOSE IV | DOSE PO | INDICATION | CONTRAINDICATION / CAUTION |
---|---|---|---|---|---|
Droperidol | Dopamine receptor antagonist and alpha receptor antagonist | 1.25–2.5 mg IV every 4 hours PRN | N/A | Antiemetic, migraine-associated nausea | QT prolongation (risk of Torsades), NMS, EPS; refer to BNF for use in pregnancy |
Esomeprazole (Nexium) | Proton pump inhibitor (inhibits parietal cell H+/K+ ATPase) | 80 mg IV bolus, then 8 mg/hour infusion (check local protocol) | N/A | Upper GI bleed (non-variceal) | Generally well tolerated acutely; refer to BNF for pregnancy advice (commonly considered relatively safe) |
Metoclopramide | Dopamine (D2) receptor antagonist in chemoreceptor trigger zone, also enhances gastric motility | 10 mg IV every 6 hours PRN | N/A | Prevention and treatment of nausea and vomiting | Risk of tardive dyskinesia, EPS, dystonia; use short-term. Check BNF for pregnancy guidance (often used if indicated) |
Octreotide | Somatostatin analogue; reduces splanchnic blood flow and portal pressure |
Bleeding varices: 50 micrograms IV bolus, then 50 micrograms/hour IV infusion
Sulfonylurea toxicity: 50 micrograms subcut every 6 hours PRN |
N/A | Bleeding oesophageal varices, sulfonylurea-induced hypoglycaemia | May precipitate biliary stasis/gallstones; check BNF for pregnancy advice |
Ondansetron | 5-HT3 serotonin receptor antagonist (centrally acting antiemetic) | 4–8 mg IV every 4–6 hours PRN | N/A | Prevention and treatment of nausea and vomiting | QT prolongation (rare risk of torsades); consult BNF for pregnancy use (commonly used if benefit outweighs risk) |